Categories
senior-management

Koji Matsuyama

Dr. Koji Matsuyama is the Founder and President of Shanton Pharma and has been engaged in researching and developing innovative drugs in pharmaceutical industry for more than 20 years.

Categories
senior-management

Celina Cabale-Scholl, Ph.D.

Celina has over 16 years of extensive experience serving in global roles leading Clinical Operations and Development professional with considerable CNS experience including infectious disease, and rare disease therapeutic area. She also has extensive experience in project/program management, outsourcing, and alliance management.

Categories
publications

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease

Categories
publications

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease

Categories
Annual Reports financials

December Quarter 2019 Results

December Quarter 2019 Results

Categories
financials SEC Filings

December Quarter 2019 Results

December Quarter 2019 Results

Categories
financials Quarterly Reports

December Quarter 2019 Results

December Quarter 2019 Results

Categories
Annual Reports financials

December Quarter 2019 Results

December Quarter 2019 Results

Categories
disease-area

Disease Area 1

Gout is the most common form of inflammatory arthritis caused by excess uric acid, with almost 10M patient diagnosed in the US alone. US patients are primarily treated with allopurinol, febuxostat (both are xanthine-oxidase inhibitors).

Categories
disease-area

Disease Area 2

A large portion of the current market is well-controlled on generic allopurinol; however, there is still a sizeable market that are uncontrolled or unable to tolerate 1st line allopurinol that have an unmet need for a safe and effective agent.